Orin
MSNYSE·Financial - Capital Markets

Morgan Stanley

Market cap $295.5BP/E 14.7× trailingGross margin —Reports Thu 14 Jan 2027, before the open
$186.91
+3.42 (+1.86%)Tue 27 Oct close 16:00 ET
52-wk $152.80 – $232.25
Orin's take
6out of 10 — how sure Orin is of this read

Orin's own judgment of how firmly the evidence points one way — not the chance the price goes up.

Refreshed 16 Oct, the 7th take on MS. A new filing or a print queues the next refresh.

Morgan Stanley posted another earnings beat in Q3 2026 with EPS of $3.03 versus $2.93 estimated, extending five consecutive quarters of ROTCE above 20% on record wealth management revenues and surging equity trading.

FY2025 fundamentals are strong — revenue of $114.98B (+11.5% YoY) and net income of $16.86B (+25.9% YoY) — and EV/EBITDA of 9.60x trades at a 54% discount to the peer median of 20.99x. However, the stock has broken below its 200-day MA of $194.31 to $180.54 with RSI at a deeply oversold 25.34, and persistent insider selling — 45 dispositions with zero acquisitions over 24 months, including MUFG unloading 1.34M shares — signals caution despite the compelling valuation discount.

What could go wrong

  • Technical breakdown. Stock at $180.54 trades below both the 50-day MA of $204.33 and the 200-day MA of $194.31, with a bearish MACD histogram of -0.41, indicating a downtrend that may not reverse quickly despite oversold conditions.
  • Persistent insider selling. Over 24 months, insiders executed 45 dispositions and zero acquisitions, netting -599,405 shares; MUFG alone sold 1.34M shares on 22 Sep at $212.57, continuing a pattern of large block sales.
  • Valuation premium on earnings. PE of 14.24x sits 16.1% above the peer median of 12.27x, and PS of 2.19x is 12.0% above the peer median of 1.96x, limiting multiple expansion upside relative to peers like BAC and C.
  • Rate and macro headwinds. Hotter CPI data reported on 14 Oct sent futures lower and yields higher, creating a potentially less favorable backdrop for capital markets activity and net interest income into Q4 2026.

What would change my mind

Technical stabilization. RSI recovers above 35 and stock closes back above the 200-day MA of $194.31 on above-average volumebullish
Sustained ROTCE streak break. Q4 2026 ROTCE falls below 20%, ending the five-quarter streakbearish
Insider buying reversal. Any insider acquisition or cessation of MUFG block sales over a full quarterbullish
Further technical deterioration. Stock breaks below $170 on heavy volume, confirming the downtrend despite oversold readingsbearish

Where this comes from: Q3 2026 earnings vs estimates and results · FY25 fundamentals · technicals, 16 Oct · peer comparison. Orin's read on MS; not advice.

How has the share price moved?

27 Oct 2025 – 27 Oct 2026

Up 12.6% over twelve months, from $166.02 on 27 Oct 2025 to $186.91 at the Tue 27 Oct 2026 close. Its highest close in that time was $228.55 on 15 Jul 2026; the last close is 18.2% below it.

Jan 2026AprJulOct
    • Green line: the closing price each trading day.
    • Grey line: the average closing price over the last 50 trading days.
    • Dashed amber line: the same over the last 200 trading days — a slower, smoother line.
    • Bars along the bottom: shares traded each day — green when it closed higher than the day before, rose when lower (the most, 14.6M, on 20 Mar 2026).
    • Flags: the company's filings, on the day they were made (a 10-Q is the quarterly report and a 10-K the annual report; an 8-K reports a major event).

    Largest holders · 13F Q2 2026

    Money flow
    FilerPositionOf fund
    State Street$20.8B0.6%
    BlackRock$19.8B0.3%
    Vanguard Capital Management$16.2B0.3%
    JPMorgan Chase$9.4B0.5%
    Vanguard Portfolio Management$6.3B0.3%
    Geode Capital Management$5.7B0.3%
    FMR$5.2B0.2%
    T. Rowe Price Associates$4.0B0.4%
    Capital Research Global Investors$3.8B0.5%
    Norges Bank$3.8B0.4%

    156 of the 815 filers we track · quarter ended Q2 2026 · positions, not flows

    Insiders, last 24 months: 153 Form 4 filings; open-market trades net −$98.7M. Of the 50 on hand, 0 were open-market purchases and 17 sales — the rest are grants, option exercises and tax withholding.

    Ask Orin about MS

    its filings · its transcripts · its numbers

    Orin answers questions about MS from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

    Start 3 free days →

    How is it priced, against its own past and its sector?

    Tue 27 Oct close

    Priced at 14.7× its last 12 months of profit (Tue 27 Oct close) — higher than in 2 of its last 5 fiscal years (middle 15.6×); the typical Financial Services company on the NYSE is at 17.6×.

    MeasureNowIts usualSector
    P/E14.7×below usual15.6×17.6×
    P/S2.27×near usual2.30×—
    P/B2.5×above usual1.7×—
    • P/S: for a bank, sales here are gross revenue — interest income plus non-interest revenue, before the interest it pays — so its P/S reads lower than it would on the net revenue in its filings.
    • EV/EBITDA: not used for a lender — the debt in its enterprise value is mostly the deposits it lends out.
    • "Its usual" is the middle of its own last 5 fiscal years.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    P/S: the company's total market value divided by one year of revenue. Used when there is no profit to measure.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    P/B: the share price divided by the book value per share — what the company owns minus what it owes, as its accounts record it. When book value is tiny, P/B swings wildly and says little.

    What do the analysts who cover it publish?

    18 firms rated it in the last 18 months · 27 Oct

    The analysts' average 12-month price target is $212 (from $195 to $236) — 13% above the Tue 27 Oct close price. That is their published opinion, not Orin's.

    Average price target

    $212

    $195 – $236 · +13% against the last close

    Their ratings
    • 9 buy or overweight
    • 8 hold
    • 1 underweight or sell

    Price target: the share price an analyst publishes for about 12 months ahead. It is the opinion of the firm that wrote it; the average is across the firms that cover the company.

    Overweight / underweight: analysts' rating words: overweight means the firm expects the stock to do better than the others it covers, underweight worse. Their words, not Orin's.

    How is it priced next to the companies it is compared to?

    middle P/E 12.4× · 4 of 4 with a profit

    Priced at 14.7× its last 12 months of profit; the middle P/E of the 4 companies it is compared to that made a profit is 12.4×.

    CompanyMarket valueP/EEV/EBITDAGross marginNet marginROE
    MSMorgan Stanley$295B14.7×n/an/a15.8%18%
    BACBank of America Corporation$351B11.9×n/an/a16.5%11%
    CCitigroup Inc.$206B11.8×n/an/a12.5%9%
    GSThe Goldman Sachs Group, Inc.$265B12.9×n/an/a18.0%18%
    JPMJPMorgan Chase & Co.$893B14.1×n/an/a21.9%18%
    • MS, BAC, C, GS, JPM: gross margin is not used (n/a) for a bank, an insurer or a property trust — what it sells is money or space, not goods.
    • MS, BAC, C, GS, JPM: EV/EBITDA is not used (n/a) for a lender — the debt in its enterprise value is mostly the deposits it lends out.
    • The list of companies is the data vendor's choice, so it can include a company a person would not have picked.

    Market value: the share price times the number of shares — what the whole company is priced at.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    Gross margin: the share of each $1 of sales left after the direct cost of making what was sold.

    Net margin: the share of each $1 of sales kept as profit after every cost. Below zero, the company lost money.

    ROE: return on equity: one year of profit as a share of the shareholders' money in the business (its book value).

    Is it priced high or low compared with its own past?

    Tue 27 Oct

    Priced at 14.7× its last 12 months of profit (Tue 27 Oct close). It has no full fiscal year on file since its history starts, so there is nothing of its own to compare with.

    • Now14.7×

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    Fiscal year (FY): the company's own 12-month accounting year, which need not match the calendar year.

    How has its sector been priced?

    Now–Now · Tue 27 Oct

    Financial Services companies on the NYSE were priced at a typical 17.6× their yearly profit (Tue 27 Oct close).

    • Now17.6×
    • Each year is the middle of that calendar year's daily sector P/E; "Now" is the Tue 27 Oct close figure, the same one in the table above.

    Sector P/E: the middle P/E of the companies in the same sector on the same stock exchange, as the data vendor works it out each day.

    What does a cash-flow model say a share is worth?

    A cash-flow model is not built for a bank or an insurer — its cash moves with deposits, loans and claims — so none is shown.

    Discounted cash flow: a model's estimate of what the company is worth today, from the cash it is forecast to make in future years. Small changes in the forecast move it a lot, and it says little about a company that loses money.